Comprehensive genetic thrombophilia panel analysis encompasses testing for a range of genetic mutations associated with an increased risk of thrombosis, including Factor V Leiden, prothrombin gene mutation, MTHFR mutation, and deficiencies in protein C, protein S, and antithrombin [17,18,19]. This evidence concerns the gene F2 and thrombophilia.